Bit Capital Gmb H Beam Therapeutics Inc. Transaction History
Bit Capital Gmb H
- $1.17 Trillion
- Q1 2025
A detailed history of Bit Capital Gmb H transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 15,771 shares of BEAM stock, worth $264,321. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,771
Previous 35,414
55.47%
Holding current value
$264,321
Previous $878 Million
64.93%
% of portfolio
0.03%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
258Shares Held
93.6MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$166 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$149 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$142 Million1.79% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$128 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$76.1 Million72.77% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.18B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...